CNTB insider transaction filings
Connect Biopharma Holdings Ltd — 6 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-07-01. Screen CNTB transaction legs live →
Insider transaction summary — last 90 days
2026-06-24 to 2026-09-22, from the filings listed below: 2 Form 4 filings. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 2.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| LIU JEAN I — Director | 1 | — | — | 1 |
| Xanthopoulos Kleanthis Gabriel — Director | 1 | — | — | 1 |
Recent Form 4 filings — Connect Biopharma Holdings Ltd
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-01 | 4 | Xanthopoulos Kleanthis Gabriel — Director | Grant/award (A): 3,738 @ $0 | EDGAR |
| 2026-07-01 | 4 | LIU JEAN I — Director | Grant/award (A): 6,718 @ $0 | EDGAR |
| 2026-06-02 | 4 | Huang James — Director | Purchase (P): 150,000 @ $2.48 | EDGAR |
| 2026-04-02 | 4 | Xanthopoulos Kleanthis Gabriel — Director | Grant/award (A): 2,816 @ $0 | EDGAR |
| 2026-04-02 | 4 | LIU JEAN I — Director | Grant/award (A): 5,061 @ $0 | EDGAR |
| 2026-04-01 | 4 | Huang James — Director | Purchase (P): 1,160,000 @ $3.45 | EDGAR |
Recent 8-K events — Connect Biopharma Holdings Ltd
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-15 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-23 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-09-16 | 8-K | 7.01 — Regulation FD Disclosure | EDGAR |
| 2025-08-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CNTB returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →